Overview

Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients

Status:
Completed
Trial end date:
2017-06-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prolong the time to reinfection with Pseudomonas aeruginosa after successfully treated acute or intermittent infection.
Phase:
Phase 3
Details
Lead Sponsor:
Mukoviszidose Institut gGmbH
Treatments:
Antibodies
Immunoglobulins
Pharmaceutical Solutions